These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 36934974)

  • 1. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis.
    Sugai S; Yamawaki K; Sekizuka T; Haino K; Yoshihara K; Nishijima K
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101197. PubMed ID: 37865220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placenta Accreta Spectrum Without Placenta Previa.
    Carusi DA; Fox KA; Lyell DJ; Perlman NC; Aalipour S; Einerson BD; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2020 Sep; 136(3):458-465. PubMed ID: 32769646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis.
    Hessami K; Salmanian B; Einerson BD; Carusi DA; Shamshirsaz AA; Shainker SA; Subramaniam A; Shrivastava VK; Nieto-Calvache AJ; Gilner JB; Khandelwal M; Backer-Meurke S; Cimic A; Aalipour S; Grace MR; Fox KA; Lyell DJ; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2022 Oct; 140(4):599-606. PubMed ID: 36075058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis.
    Lucidi A; Janiaux E; Hussein AM; Nieto-Calvache A; Khalil A; D'Amico A; Rizzo G; D'Antonio F
    Am J Obstet Gynecol MFM; 2024 Oct; 6(10):101432. PubMed ID: 39069207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Morbidity with Repeated Cesarean Deliveries.
    Klahr R; Cheung K; Markovic ES; Naert M; Rebarber A; Fox NS
    Am J Perinatol; 2023 Oct; 40(13):1431-1436. PubMed ID: 34583410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel transverse uterine incisions, a novel approach for managing heavy hemorrhage and preserving the uterus: A retrospective cohort study for patients with anterior placenta previa and accreta.
    Peng X; Chen D; Xu J; Liu X; You Y; Peng B
    Medicine (Baltimore); 2019 Nov; 98(44):e17742. PubMed ID: 31689824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis.
    Sugai S; Yamawaki K; Sekizuka T; Haino K; Yoshihara K; Nishijima K
    Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101027. PubMed ID: 37211089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery.
    Matsuzaki S; Rau AR; Mandelbaum RS; Tavakoli A; Mazza GR; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101115. PubMed ID: 37543142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
    Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center.
    Varlas VN; Bors RG; Birsanu S; Maxim B; Clotea E; Mihailov M
    J Med Life; 2021; 14(3):367-375. PubMed ID: 34377203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.
    Jauniaux E; Bhide A
    Am J Obstet Gynecol; 2017 Jul; 217(1):27-36. PubMed ID: 28268196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
    Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa.
    Mulla BM; Weatherford R; Redhunt AM; Modest AM; Hacker MR; Hecht JL; Spiel MH; Shainker SA
    Arch Gynecol Obstet; 2019 Dec; 300(6):1601-1606. PubMed ID: 31691015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
    Marcellin L; Delorme P; Bonnet MP; Grange G; Kayem G; Tsatsaris V; Goffinet F
    Am J Obstet Gynecol; 2018 Aug; 219(2):193.e1-193.e9. PubMed ID: 29733839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripartum hysterectomy clinical characteristics and outcomes- a hospital based retrospective audit study.
    Nor AM; Jagdeesh K; Mohd FAS; Kamraul AK; Yusmadi A; Noraslawati R; Malina O; Roziana R
    Med J Malaysia; 2023 Nov; 78(6):756-762. PubMed ID: 38031217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.